BILL ANALYSIS Ó
AB 1136
Page 1
Date of Hearing: May 8, 2013
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Mike Gatto, Chair
AB 1136 (Levine) - As Amended: April 15, 2013
Policy Committee: HealthVote:11-1
Business, Professions and Consumer Protection12-0
Urgency: No State Mandated Local Program:
Yes Reimbursable: No
SUMMARY
This bill requires a pharmacist, after July 1, 2014, to include
a written warning label on a prescription drug if the pharmacist
determines the drug may impair a person's ability to operate a
vehicle or vessel.
FISCAL EFFECT
Negligible state costs.
COMMENTS
1)Rationale . This bill is intended to combat the growing
epidemic of drugged driving by mandating best practices among
California pharmacies to ensure that warning labels are
included on dangerous drugs. If the pharmacist determines a
drug may impair a person's ability to operate a vehicle or
vessel, this bill would require a written warning.
2)Previous legislation . SB 472 (Corbett), Chapter 470, Statutes
of 2007, requires the Board of Pharmacy (BOP) to promulgate
regulations that require, on or before January 1, 2011, a
standardized, patient-centered, prescription drug label on all
prescription medication dispensed to patients in California.
3)Related legislation . SB 204 (Corbett) requires a pharmacist to
use translations of the directions for drug use in non-English
languages published on the Board's Internet Web site, as
applicable, when labeling a prescription container and
authorizes a pharmacist to translate the directions for drug
use into additional non-English languages if certified
AB 1136
Page 2
translation services are utilized to complete the additional
translations. SB 204 is pending in Senate Appropriations
Committee.
SB 205 (Corbett) requires the information on a prescription
label to be printed in at least a 12-point sans serif
typeface. SB 205 is pending in Senate Appropriations
Committee.
SB 289 (Correa) makes it unlawful for a person to drive a
motor vehicle if his or her blood contains any detectable
amount of a drug classified in Schedules I, II, III, or IV of
the California Uniform Controlled Substance Act, unless the
drug was consumed in accordance with a valid prescription
issued to the person by a licensed health care practitioner.
SB 289 failed pending in Senate Public Safety.
Analysis Prepared by : Debra Roth / APPR. / (916) 319-2081